| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |